Drug Patents owned by Amgen

1. List of Sensipar drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7829595 AMGEN Rapid dissolution formulation of a calcium receptor-active compound
Sep, 2026

(3 years from now)

US9375405 AMGEN Rapid dissolution formulation of a calcium receptor-active compound
Sep, 2026

(3 years from now)

Drugs and Companies using CINACALCET HYDROCHLORIDE ingredient

Market Authorisation Date: 08 March, 2004

Treatment: Method of treating hyperparathyroidism; Method of treating hypercalcemia

Dosage: TABLET;ORAL

How can I launch a generic of SENSIPAR before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic